美的集團(000333.SZ)漲近2% 公佈2019年度利潤分配方案
格隆匯5月27日丨美的集團(000333.SZ)逆勢上漲,現漲1.76%報59.02元,暫成交9.1億元,最新總市值4130億元。該股自3月23日反彈至今,累計反彈幅度逼近30%。公司昨晚公佈2019年度利潤分配方案的具體內容:向全體股東每10股派發現金16元(含税),派發現金共計111.31億元,不以公積金轉增股本。另外,來自交易所的數據顯示,截至5月25日,外資持有美的集團的比例為27.31%。根據相關規定,所有境外投資者對單一上市公司的A股持股比例總和,不得超過該上市公司股份總數的30%。但在實際操作中,外資持股比例達26%視為警戒點,28%則暫停外資購買。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.